Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04812093 · ClinicalTrials.gov registry record
Spectroscopic Evaluation of Middle Ear Infection
A clinical trial of Middle Ear Infection, sponsored by University of California, Irvine.
- Recruiting
- Registry status
- 150
- Enrollment target
- 2
- Study locations
NCT04812093: Recruiting study of Middle Ear Infection, sponsored by University of California, Irvine.
NCT04812093 is a study of Middle Ear Infection that is actively recruiting participants, run by University of California, Irvine. The registered enrollment target is 150 participants. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04812093, a study of Middle Ear Infection, is actively recruiting participants, sponsored by University of California, Irvine.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 2
- Study locations
Study Summary
Otitis media is more common in young children and it is estimated that 75% of all children experience at least one episode before the age of three. Otitis media is one of the common pediatric diagnoses and recurrent episodes account for the most commonly performed surgical procedure. Despite this a high degree of inaccuracy exists in diagnosis of this condition which depends on subjective assessment of the ear drum via direct visualization using an otoscope. Researchers can use LED-based multi wavelength light absorption and scattering measurements for the analysis of ear drum and the middle ear.
Primary Outcome
The level of light scattering and absorption as measured will be the predictor and presence of fluid behind the ear drum as determined by the surgeon during ear tube placement procedure will be our outcome variable.
Conditions Studied
Interventions
- DEVICE Spectroscopic otoscope measurements
Study Locations (2)
California
- Children's Hospital of Orange County (CHOC) - Orange
- UCI Otolaryngology Clinic - Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2021-02-26 |
| Est. Completion | 2028-12-31 |
What NCT04812093 shows while recruiting
NCT04812093 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Middle Ear Infection appearing as the primary indexed condition, and to 1 intervention - of which Spectroscopic otoscope measurements is the first listed.
NCT04812093 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04812093 about?
NCT04812093 is a clinical study titled "Spectroscopic Evaluation of Middle Ear Infection". Otitis media is more common in young children and it is estimated that 75% of all children experience at least one episode before the age of three. Otitis media is one of the common pediatric diagnoses and recurrent episodes account for the most commonly performed surgical procedure. Despite this a ...
What is the current status of trial NCT04812093?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2021-02-26. Estimated completion is 2028-12-31.
What conditions does trial NCT04812093 study?
This clinical trial studies the following conditions: Middle Ear Infection.
What interventions are being tested in trial NCT04812093?
The interventions under investigation include: Spectroscopic otoscope measurements (DEVICE).
Who is sponsoring clinical trial NCT04812093?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04812093 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Middle Ear Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI